New hope for treating AIDS-Related cancer in Resource-Poor regions
NCT ID NCT05411237
Summary
This study aims to determine if two different chemotherapy drugs work equally well for treating Kaposi sarcoma in people living with HIV in sub-Saharan Africa. The trial will compare paclitaxel against pegylated liposomal doxorubicin, with participants receiving one of these drugs every three weeks for six cycles. Researchers want to see which treatment better controls the cancer while causing fewer side effects in resource-limited settings.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KAPOSI SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.